Literature DB >> 2201260

New insights into the haemolytic uraemic syndromes.

D V Milford1, C M Taylor.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2201260      PMCID： PMC1792434          DOI： 10.1136/adc.65.7.713

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  27 in total

1.  Thrombogenic activity of leukocytes.

Authors:  J Niemetz; K Fani
Journal:  Blood       Date:  1973-07       Impact factor: 22.113

2.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

3.  The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome.

Authors:  C M Taylor; D V Milford; P E Rose; T C Roy; B Rowe
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

4.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes.

Authors:  F Koster; J Levin; L Walker; K S Tung; R H Gilman; M M Rahaman; M A Majid; S Islam; R C Williams
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

5.  The importance of nonrenal involvement in hemolytic-uremic syndrome.

Authors:  K Upadhyaya; K Barwick; M Fishaut; M Kashgarian; N J Siegel
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

6.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

7.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

8.  An animal model of haemolytic--uraemic syndrome in shigellosis: lipopolysaccharides of Shigella dysenteriae I and S. flexneri produce leucocyte-mediated renal cortical necrosis in rabbits.

Authors:  T Butler; H Rahman; K A Al-Mahmud; M Islam; P Bardhan; I Kabir; M M Rahman
Journal:  Br J Exp Pathol       Date:  1985-02

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Self-regulation of procoagulant events on the endothelial cell surface.

Authors:  D M Stern; I Bank; P P Nawroth; J Cassimeris; W Kisiel; J W Fenton; C Dinarello; L Chess; E A Jaffe
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307
View more
  5 in total

1.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

Review 2.  Reactive oxygen molecules, oxidant injury and renal disease.

Authors:  S P Andreoli
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

3.  Hypoproteinemia in the hemolytic-uremic syndrome of childhood.

Authors:  V L Serebruany; M J Christenson; J Pescetti; R H McLean
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

4.  Dilated cardiomyopathy: A rare and late complication of the hemolytic-uremic syndrome.

Authors:  Oumaima Naour; Abdenasser Drighil; Kaoutar Idouz; Sellama Nadifi; Fatima Ezzahra Rochdi; Kenza Bouayed; Nabiha Mikou
Journal:  J Cardiol Cases       Date:  2019-08-02

5.  Mitomycin immunoblot colony assay for detection of Shiga-like toxin-producing Escherichia coli in fecal samples: comparison with DNA probes.

Authors:  A E Hull; D W Acheson; P Echeverria; A Donohue-Rolfe; G T Keusch
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.